Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.
VRBPAC unanimously recommends monovalent, XBB lineage for next fall’s Covid-19 vaccine campaign
The FDA’s Vaccines and Related Biological Products Advisory Committee met Thursday to assess whether the Covid-19 vaccine needs to be updated, with the committee voting